Episode notes
On September 30, 2026, Google DeepMind announced SynthID Bio, a family of methods for embedding imperceptible provenance signatures into AI-generated protein sequences and predicted three-dimensional structures. The work was published as a proof-of-concept study titled "Function-preserving watermarking of AI-generated proteins" in Nature.
More from Onpode All episodes →
-
15 Oct 2026 · 8 minNew
Why infinite parallel universes let writers reset consequences and explore absurdist premises
Rick and Morty is an American adult animated science fiction sitcom created by Justin Roiland and Dan Harmon, premiering December 2, 2013, on Adult Swim (Cartoon Network's late-night programming block).
-
15 Oct 2026 · 8 minNew
Original Rosalina voice actor laments the Mario narration that never was
Mercedes Rose, born Mercedes Cochran, is an American actress and voice-over artist best known as the original English-language voice of Rosalina in Nintendo's Mario franchise. She voiced the character in Super Mario Galaxy (2007), Mario Kart Wii (2008), Super Mario Galaxy 2, and Super Mario 3D All-Stars, before being succeeded by Kerri Kane.
-
15 Oct 2026 · 9 minNew
After stepping back from politics last year, Musk is back in DC with $366 million in election spending
Elon Musk has re-emerged as a dominant force in U.S. politics ahead of the 2026 midterm elections after a period of public withdrawal from both President Trump's orbit and political spending.
-
15 Oct 2026 · 10 minNew
Musk says US government, not SpaceX, imposed Starlink limits on Ukraine's attack drones
On or around October 14, 2026, Ukrainian officials accused SpaceX of imposing a new speed restriction on Starlink and Starshield terminals, reportedly cutting satellite connectivity for terminals moving faster than approximately 160 kilometers per hour (100 mph).
-
15 Oct 2026 · 9 minNew
Palantir AIP explained: how FDEs are using the AI platform in practice today
Palantir Technologies has developed the Artificial Intelligence Platform (AIP) as the generative-AI layer that sits atop its existing Foundry and Gotham products.
-
14 Oct 2026 · 13 minNew
Why transistor density can't double forever — the quantum tunneling wall
Moore's Law is an empirical industry observation, not a physical law, originally articulated by Intel co-founder Gordon Moore in 1965. Moore projected that the number of components on an integrated circuit would double approximately every year; in 1975 he revised this to roughly every two years.
-
14 Oct 2026 · 8 minNew
Apple's billions of devices give Siri-powered smart home hubs an unfair advantage over OpenAI and Anthropic
On October 13, 2026, Apple announced a suite of new smart home products: the second-generation HomePod mini, an updated Apple TV 4K, and a new screen-equipped hub called HomeView. The HomePod mini 2 is priced at $149 (up from $129) and launched for preorder on October 13, with general availability on October 30, 2026. The Apple TV 4K and HomeView are priced at $299.
-
14 Oct 2026 · 8 minNew
Anthropic's IPO could turn an AI insider's biggest asset—his network—into liability
Leopold Aschenbrenner is a German-born AI researcher and investor, born 2001/2002, who entered Columbia University at age 15 and graduated as valedictorian in 2021. After a brief stint at the FTX Future Fund, he joined OpenAI's "Superalignment" team.
-
14 Oct 2026 · 9 minNew
After months trailing rivals, Google finally releases Gemini 4 Argon—claiming parity with best-in-class
Google officially released Gemini 4 Argon on October 13, 2026, making it broadly available to developers, enterprises, and consumers worldwide through the Gemini API, AI Studio, and the Gemini app for Google AI Pro and Ultra subscribers. The model is Google's first major frontier release since Gemini 3 in late 2025, and follows Google's decision to skip the previously promised Gemini 3.5 Pro.
-
14 Oct 2026 · 10 minNew
The neurobiology of expectation: why belief changes measurable physiology
The placebo effect refers to measurable psychobiological and physiological changes that occur when a patient expects relief or has learned to associate a treatment ritual with improvement — without any active pharmacological ingredient.
